Tabatabai ZL - Search Results

1

The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.

Pookot D, Li LC, Tabatabai ZL, Tanaka Y, Greene KL, Dahiya R. Pookot D, et al. Among authors: tabatabai zl. J Urol. 2006 Aug;176(2):793-6. doi: 10.1016/j.juro.2006.03.085. J Urol. 2006. PMID: 16813949

2

Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. Enokida H, et al. Among authors: tabatabai zl. Int J Cancer. 2005 Aug 20;116(2):174-81. doi: 10.1002/ijc.21017. Int J Cancer. 2005. PMID: 15800905

3

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

Hirata H, Hinoda Y, Kikuno N, Suehiro Y, Shahryari V, Ahmad AE, Tabatabai ZL, Igawa M, Dahiya R. Hirata H, et al. Among authors: tabatabai zl. J Urol. 2009 Apr;181(4):1907-12. doi: 10.1016/j.juro.2008.11.093. Epub 2009 Feb 23. J Urol. 2009. PMID: 19237173

4

The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.

Hirata H, Hinoda Y, Nakajima K, Kikuno N, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R. Hirata H, et al. Among authors: tabatabai zl. J Urol. 2009 Aug;182(2):721-7. doi: 10.1016/j.juro.2009.03.081. Epub 2009 Jun 18. J Urol. 2009. PMID: 19539330

5

Wnt antagonist gene polymorphisms and renal cancer.

Hirata H, Hinoda Y, Nakajima K, Kikuno N, Yamamura S, Kawakami K, Suehiro Y, Tabatabai ZL, Ishii N, Dahiya R. Hirata H, et al. Among authors: tabatabai zl. Cancer. 2009 Oct 1;115(19):4488-503. doi: 10.1002/cncr.24491. Cancer. 2009. PMID: 19562778 Free PMC article.

6

Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma.

Ueno K, Hirata H, Shahryari V, Chen Y, Zaman MS, Singh K, Tabatabai ZL, Hinoda Y, Dahiya R. Ueno K, et al. Among authors: tabatabai zl. Br J Cancer. 2011 Jan 18;104(2):308-15. doi: 10.1038/sj.bjc.6606028. Epub 2010 Nov 30. Br J Cancer. 2011. PMID: 21119662 Free PMC article.

7

IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, Dahiya R. Ueno K, et al. Among authors: tabatabai zl. Int J Cancer. 2011 Nov 15;129(10):2360-9. doi: 10.1002/ijc.25899. Epub 2011 Apr 7. Int J Cancer. 2011. PMID: 21207373

8

Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Chen Y, Zaman MS, Tabatabai ZL, Hinoda Y, Dahiya R. Ueno K, et al. Among authors: tabatabai zl. Mol Carcinog. 2011 Jun;50(6):449-57. doi: 10.1002/mc.20729. Epub 2011 Jan 25. Mol Carcinog. 2011. PMID: 21268126

9

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.

Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, Tanaka Y, Dahiya R. Suh SO, et al. Among authors: tabatabai zl. Carcinogenesis. 2011 May;32(5):772-8. doi: 10.1093/carcin/bgr036. Epub 2011 Feb 23. Carcinogenesis. 2011. PMID: 21349819 Free PMC article.

10

DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.

Hirata H, Hinoda Y, Majid S, Chen Y, Zaman MS, Ueno K, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R. Hirata H, et al. Among authors: tabatabai zl. Cancer. 2011 Apr 15;117(8):1649-60. doi: 10.1002/cncr.25666. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472712 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters